MECHANISMS OF BPD PATHOGENESIS

BPD 发病机制

• 批准号: 8403668
• 负责人: Parviz Minoo Minoo
• 金额: $ 38.94万
• 依托单位: UNIVERSITY OF SOUTHERN CALIFORNIA
• 依托单位国家: 美国
• 财政年份: 2012
• 资助国家: 美国
• 起止时间: 2012-01-01 至 2015-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8403668
• 关键词: Address; Adult; Alveolar; Arts; Behavior; Bleomycin; Blood Vessels; Borderline Personality Disorder; Bronchopulmonary Dysplasia; Cell Proliferation; Cells; Chronic lung disease; Consensus; Data; Defect; Development; Ectopic Expression; Employee Strikes; Epithelial; Experimental Models; FGF10 gene; Fibrosis; Genetically Engineered Mouse; Growth Factor; Histologic; Human; Hyperoxia; In Vitro; Infant; Injury; Interruption; Link; Lung; Measures; Mediating; Mesenchymal; Mesenchyme; Modeling; Molecular Genetics; Morphogenesis; Mus; Neonatal; Newborn Animals; PIK3CG gene; Pathogenesis; Pathway interactions; Premature Birth; Premature Infant; Process; Pulmonary Fibrosis; Research Project Grants; Rest; Role; Severities; Signal Pathway; Signal Transduction; Signaling Molecule; Stem cells; Testing; Time; Transforming Growth Factor beta; Transgenic Mice; abstracting; base; in utero; in vivo; in vivo Model; lung development; lung injury; mouse model; overexpression; receptor; research study

ABSTRACT Bronchopulmonary Dysplasia or BPD is a chronic lung disease that results from interruption of normal in utero lung development by premature birth. We have shown that bioactive TGFbeta in the lungs of human preterm infants predicts severity of BPD, suggesting a possible role in its pathogenesis and arrested lung development. Another key signaling molecule with suggested role in pathogenesis of BPD is FGF10 which was recently found to be decreased significantly in BPD lungs. Our preliminary studies establish an operational link between FGF10 & TGFbeta through the Pten/PI3k/Akt/Erk pathway. We have further shown that FGF10 can protect lungs from TGF-beta‐induced fibrosis in mice. This project will use simple genetic and molecular approaches to address the role of TGFbeta & FGF10 in pathogenesis of BPD. The logical basis for the current proposal rests on a number of preliminary, but important data that collectively, support the following overall hypothesis: HYPOTHESIS: We hypothesize that TGFbeta signaling via TRII derails lung morphogenesis by inhibiting epithelial progenitor cell proliferation, mediated thru increased Pten, which leads to inhibition of PI3k/Akt/Erk pathway. We further hypothesize that FGF10 can protect the neonatal lung from hyperoxia/TGF-mediated injury & BPD at least in part by countering the inhibitory effect of TGFon the PI3k/Akt/Erk pathway. The following specific aims will test the validity of the above hypothesis Specific Aim 1. To Determine the Precise Pathway via Which TGFInhibits Epithelial Progenitor Cell Proliferation and Morphogenesis in both in vitro & in vivo Models. The availability of genetically engineered mice offers an unprecedented opportunity to elucidate the precise role of a key target of TGF, Pten, & its signaling target, the PI3k/Akt/Erk pathway in both in vitro & in vivo settings. Specific Aim 2. To determine the Potential Role of TbetaRII in Epithelial & Mesenchymal Compartments of the Lung in Pathogenesis of Hyperoxia-¿Induced Hypoalveolization in Neonatal Mice (The mouse BPD Model). Mice carrying either Epithelial-¿‐ or Mesenchymal-¿‐specific deletion of TbetaRII will be exposed to hyperoxia and the process of alveolization will be measured by state-¿‐of-¿‐the-¿‐art technical approaches. Specific Aim 3. To Determine the Role of FGF10 in a Murine Model of Hyperoxia-¿Induced Hypoalveolization. We have shown that mesenchymal deletion of TbetaRII leads to increaseded FGF10. Remarkably regulated ectopic expression of Fgf10 in transgenic mice protects from bleomycin-¿‐induced adult lung injury. In this aim, we will test the hypothesis that ectopic Fgf10 also protects from hyperoxia-¿‐induced lung injury in neonatal transgenic mice. As in Specific Aim 1, the focus of the mechanisms in this aim will be the PI3k/Akt/Erk pathway.

摘要支气管肺发育不良（BPD）是一种慢性肺部疾病，由于早产导致子宫内肺发育中断。我们已经证明，人类早产儿肺部的生物活性TGF β可预测BPD的严重程度，这表明其在发病机制和肺部发育受阻中可能发挥作用。另一个在BPD发病机制中发挥作用的关键信号分子是FGF 10，最近发现它在BPD肺部显着减少。我们的初步研究通过Pten/PI 3 k/Akt/Erk途径建立了FGF 10和TGF β之间的操作联系。我们进一步表明，FGF 10可以保护小鼠肺免受TGF-β诱导的纤维化。该项目将使用简单的遗传和分子方法来解决TGF β和FGF 10在BPD发病机制中的作用。目前建议的逻辑基础依赖于一些初步的但重要的数据，这些数据共同支持以下总体假设：假设：我们假设TGF β通过TRII的信号传导通过抑制上皮祖细胞增殖来破坏肺形态发生，通过增加Pten介导，这导致PI 3 k/Akt/Erk途径的抑制。我们进一步假设FGF 10可以保护新生儿肺免受高氧/TGF介导的损伤& BPD，至少部分是通过对抗TGF对PI 3 k/Akt/Erk通路的抑制作用。以下具体目标将检验上述假设具体目标1的有效性。确定TGF在体外和体内模型中抑制上皮祖细胞增殖和形态发生的精确途径。基因工程小鼠的可用性提供了前所未有的机会，以阐明TGF，Pten及其信号传导靶点，PI 3 k/Akt/Erk通路在体外和体内环境中的关键靶点的精确作用。具体目标2。确定TbetaRII在新生小鼠（小鼠BPD模型）中高氧诱导肺泡形成的发病机制中肺上皮和间质复合物中的潜在作用。将携带TbetaRII的上皮特异性缺失或间充质特异性缺失的小鼠暴露于高氧，并通过最先进的技术方法测量肺泡化过程。具体目标3。确定FGF 10在高氧诱导的肺泡发育不良小鼠模型中的作用。我们已经表明，间充质TbetaRII缺失导致FGF 10增加。Fgf 10在转基因小鼠中的显著调节的异位表达保护博来霉素诱导的成年肺损伤。在这个目标中，我们将测试异位Fgf 10也保护新生转基因小鼠免受高氧诱导的肺损伤的假设。与具体目标1中一样，该目标中的机制的焦点将是PI 3 k/Akt/Erk途径。